Search results
Bristol-Myers Squibb (NYSE:BMY) Forecasted to Post Q3 2024 Earnings of $1.67 Per Share
ETF DAILY NEWS· 6 days agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Analysts at Zacks Research cut their Q3 2024 earnings per share (EPS) estimates for Bristol-Myers Squibb in a note issued to investors on Tuesday ...
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 2 days agoBristol Myers Squibb (BMY) is one of the stocks most watched by Zacks.com visitors lately. So, it...
Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions
Benzinga via Yahoo Finance· 6 days agoThursday, Bristol Myers Squibb & Co (NYSE:BMY) posted first-quarter revenues of $11.9 billion,...
A Closer Look at Bristol-Myers Squibb's Options Market Dynamics - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 2 days agoLoading... Loading... Financial giants have made a conspicuous bearish move on Bristol-Myers Squibb. Our analysis of options history for Bristol-Myers Squibb BMY revealed 9 unusual trades. Delving ...
Bristol Myers Squibb Posts Loss In Q1; Updates 2024 Non-GAAP EPS Guidance
RTT News· 7 days agoBristol Myers Squibb (BMY) posted a first quarter net loss attributable to Bristol Myers Squibb of $11.9 billion, or $5.89 per share, compared to net income of $2.
Merck and Bristol-Myers Squibb are bracing to lose their most lucrative patents
Quartz· 6 days agoPharma giants Merck and Bristol-Myers Squibb are both getting ready for some of their key drug...
Bristol Myers Squibb to Shut 256K sf Campus in Redwood City
The Real Deal· 5 days agoBristol Myers Squibb will close a 256,000-square-foot campus in Redwood City and squish operations...
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
CNBC· 2 days agoA federal judge in New Jersey on Monday rejected Johnson & Johnson's and Bristol Myers Squibb's...
Why Is Bristol Myers Squibb Stock Trading Lower On Thursday? - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 7 days agoThursday, Bristol Myers Squibb & Co BMY posted first-quarter revenues of $11.9 billion, beating the...
Bristol-Myers Squibb stock target cut on cost cutting measures By Investing.com
Investing.com· 3 days agoOn Monday, Deutsche Bank (ETR:DBKGn) adjusted its outlook on Bristol-Myers Squibb Co. shares...